Merck KGaA completes acquisition of Sigma -Aldrich for $17.0 billion

Merck KGaA, has announced that approvals have been secured from all relevant jurisdictions for its planned acquisition of U.S.-based life science company Sigma-Aldrich. On 22, September, 2014, Merck and Sigma-Aldrich had announced they entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (�13.1 billion), establishing one of the leading players in the $130 billion global life science industry. Merck Millipore and Sigma-Aldrich will offer their customers a complementary range of products across laboratory chemicals, biologics and reagents.